Join BIOCYTOGEN at EMD Serono Research & Development Institute Biotech Community Expo

We are excited to announce that we will be exhibiting at the EMD Serono Research & Development Institute Biotech Community Expo on Thursday, May 8, from 11:30 AM to 2:30 PM in Billerica, MA. This exclusive event connects EMD Serono and MilliporeSigma researchers with industry innovators, focusing on neurology, immunology, fertility, endocrinology, and oncology. With unparalleled networking opportunities, the expo fosters collaboration and advances key life sciences research. We look forward to seeing you there!

What is the EMD Serono Research & Development Institute Biotech Community Expo?

The EMD Serono Research & Development Institute Biotech Community Expo is a premier networking event that fosters collaboration between leading biotech professionals, researchers, and industry decision-makers. Sponsored by strategic procurement and product development sourcing, the expo highlights emerging technologies, innovative solutions, and drug discovery and development advancements. Attendees can explore new opportunities, exchange insights, and engage with experts driving progress in the life sciences sector.

Event Overview

Date: May 8th 11:30 AM - 2:30 PM EDT

Venue: EMD Serono, 45 Middlesex Turnpike, Billerica, MA 01821

Event Schedule

The EMD Serono Biotech Community Expo in Billerica, MA, offers direct engagement with researchers specializing in neurology & immunology, fertility, endocrinology, and oncology. For detailed information on session times and event highlights, please visit: EMD Serono.

About BIOCYTOGEN

Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

We look forward to seeing you at the EMD Serono Research & Development Institute Biotech Community Expo in Billerica, MA!